| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.201700810 |
| P698 | PubMed publication ID | 29377520 |
| P50 | author | Dirk Schepmann | Q64169252 |
| Bernhard Wünsch | Q88011614 | ||
| P2093 | author name string | Bastian Frehland | |
| Julian A Schreiber | |||
| Louisa Temme | |||
| P2860 | cites work | Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors | Q44343196 |
| Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats | Q44968379 | ||
| Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampus. | Q46005157 | ||
| Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands | Q46918756 | ||
| Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold | Q48021684 | ||
| Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands | Q48123606 | ||
| Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study | Q48738084 | ||
| Is NMDA receptor-coincidence detection required for learning and memory? | Q50802832 | ||
| Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia. | Q52146715 | ||
| Anticonvulsant action of excitatory amino acid antagonists | Q70357890 | ||
| CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents | Q73665645 | ||
| The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist | Q24629716 | ||
| Crystal structure of a heterotetrameric NMDA receptor ion channel | Q27684006 | ||
| NMDA receptor structures reveal subunit arrangement and pore architecture | Q27684638 | ||
| Activation of NMDA receptors and the mechanism of inhibition by ifenprodil | Q27704785 | ||
| Analogues of the dioxolanes dexoxadrol and etoxadrol as potential phencyclidine-like agents. Synthesis and structure-activity relationships | Q28182062 | ||
| Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol | Q28272874 | ||
| Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists | Q28296319 | ||
| Huntington's disease | Q28365461 | ||
| Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors. | Q30316361 | ||
| Mechanism of NMDA Receptor Inhibition and Activation | Q30774134 | ||
| Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain | Q34245488 | ||
| Ketamine and phencyclidine: the good, the bad and the unexpected | Q34480719 | ||
| NMDA receptor subunits: function and pharmacology. | Q34579640 | ||
| NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease | Q34651972 | ||
| Mechanism of action of memantine | Q36348056 | ||
| Neuronal coincidence detection by voltage-sensitive electrical synapses | Q36513357 | ||
| Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action | Q36937837 | ||
| NMDA receptors: recent insights and clinical correlations | Q37876054 | ||
| Influence of GluN2 subunit identity on NMDA receptor function. | Q38078685 | ||
| NMDA receptors in nervous system diseases. | Q38098824 | ||
| NMDA Receptor Activity in Neuropsychiatric Disorders | Q38114881 | ||
| Allosteric modulators of NMDA receptors: multiple sites and mechanisms. | Q38280910 | ||
| Binding of ArgTX-636 in the NMDA receptor ion channel | Q39186423 | ||
| Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain | Q39475255 | ||
| Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists. | Q39722433 | ||
| Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block. | Q40170517 | ||
| Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels | Q40421582 | ||
| A simple cell line based in vitro test system for N-methyl-D-aspartate (NMDA) receptor ligands | Q40763937 | ||
| Neuropsin cleaves EphB2 in the amygdala to control anxiety | Q41962381 | ||
| Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors. | Q42169395 | ||
| Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801. | Q42212386 | ||
| Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents | Q43111047 | ||
| Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex | Q43893552 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 446-452 | |
| P577 | publication date | 2018-01-27 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors | |
| P478 | volume | 13 |
| Q88651049 | Amantadine: A new treatment for refractory electrical status epilepticus in sleep |
| Q55438088 | Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. |
| Q88879305 | Synthesis and Pharmacological Evaluation of Enantiomerically Pure GluN2B Selective NMDA Receptor Antagonists |
Search more.